News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AbSorber AB’s Test Identifies Patients with Increased Risk for Kidney Transplant Rejection



8/18/2008 9:05:27 AM

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: LinkMed’s (STO:LMED) portfolio company AbSorber recently received FDA approval in the U.S. for its patented transplantation test XM-ONE®. Now AbSorber has received further support for its transplantation test from a major clinical trial in which six well-reputed transplantation centers in the U.S. and Sweden participated. The results of the study show that XM-ONE® provides valuable information that refines the diagnostics of matching the right organ with the right patient, thereby increasing the probability of a successful transplantation.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES